CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....